Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vanguard Information Technology Index Fund ETF (VGT) vs GeneDx Holdings Corp (WGS) Price & Performance

Vanguard Information Technology Index Fund ETFTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Vanguard Information Technology Index Fund ETF vs GeneDx Holdings Corp — how do they compare? Vanguard Information Technology Index Fund ETF trades at $121, while GeneDx Holdings Corp trades at $86.53 (market cap $2.56B). The key difference: Vanguard Information Technology Index Fund ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.

VGTWGS
52-Week High
$125.77$167.51
52-Week Low
$83.59$34.51
Market Cap
$2.56B
Sector
Technology
Enterprise Value
$2.60B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Vanguard Information Technology Index Fund ETF

VGT trades at $121.05, down slightly by 0.18% today, with a bullish technical signal from moving averages and neutral oscillators. The ETF holds a strong position in technology stocks, with recent institutional buying indicating confidence. Key support sits at $119, while resistance is at $122.

The outlook remains positive due to technology sector growth and AI exposure, but risks include high concentration in semiconductor stocks and market volatility. Long-term potential is supported by innovation trends, though investors should monitor sector-specific headwinds.

GeneDx Holdings Corp

WGS trades at $85.87, down 0.14% today, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4M, beating estimates, and returned to adjusted profitability early. However, net income remains negative at -$106M for 2026, with high valuation multiples like EV/EBITDA of 161.17. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics.

Outlook is mixed: strong analyst buy consensus (90.9%) and institutional interest support upside, but profitability challenges and a class action lawsuit pose risks. Revenue growth and operational improvements are key catalysts, yet high debt-to-asset ratios and negative margins require monitoring for sustained recovery.

Returns comparison

Trailing returns across standard periods

About Vanguard Information Technology Index Fund ETF

The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index/Information Technology 25/50, an index made up of stocks of large, mid-size, and small US companies within the information technology sector, as classified under the GICS. The advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.

Read more on VGT

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS